135 related articles for article (PubMed ID: 17366748)
1. Enhanced bioavailability of poorly water-soluble clotrimazole by inclusion with beta-cyclodextrin.
Prabagar B; Yoo BK; Woo JS; Kim JA; Rhee JD; Piao MG; Choi HG; Yong CS
Arch Pharm Res; 2007 Feb; 30(2):249-54. PubMed ID: 17366748
[TBL] [Abstract][Full Text] [Related]
2. The effect of beta-cyclodextrin complexation on the bioavailability and hepatotoxicity of clotrimazole.
Yong CS; Li DX; Prabagar B; Park BC; Yi SJ; Yoo BK; Lyoo WS; Woo JS; Rhee JD; Kim JA; Choi HG
Pharmazie; 2007 Oct; 62(10):756-9. PubMed ID: 18236780
[TBL] [Abstract][Full Text] [Related]
3. Inclusion complex effect on the bioavailability of clotrimazole from poloxamer-based solid suppository.
Balakrishnan P; Song CK; Cho HJ; Yang SG; Kim DD; Yong CS; Choi HG
Arch Pharm Res; 2012 Jul; 35(7):1169-75. PubMed ID: 22864739
[TBL] [Abstract][Full Text] [Related]
4. Improvement of dissolution and bioavailability of nitrendipine by inclusion in hydroxypropyl-beta-cyclodextrin.
Choi HG; Kim DD; Jun HW; Yoo BK; Yong CS
Drug Dev Ind Pharm; 2003 Nov; 29(10):1085-94. PubMed ID: 14677769
[TBL] [Abstract][Full Text] [Related]
5. The formation of an inclusion complex between a metabolite of ginsenoside, compound K and γ-cyclodextrin and its dissolution characteristics.
Igami K; Ozawa M; Inoue S; Iohara D; Miyazaki T; Shinoda M; Anraku M; Hirayama F; Uekama K
J Pharm Pharmacol; 2016 May; 68(5):646-54. PubMed ID: 26255976
[TBL] [Abstract][Full Text] [Related]
6. Inclusion complex of erlotinib with sulfobutyl ether-β-cyclodextrin: Preparation, characterization, in silico, in vitro and in vivo evaluation.
Devasari N; Dora CP; Singh C; Paidi SR; Kumar V; Sobhia ME; Suresh S
Carbohydr Polym; 2015 Dec; 134():547-56. PubMed ID: 26428157
[TBL] [Abstract][Full Text] [Related]
7. Mucoadhesive, thermosensitive, prolonged-release vaginal gel for clotrimazole:beta-cyclodextrin complex.
Bilensoy E; Rouf MA; Vural I; Sen M; Hincal AA
AAPS PharmSciTech; 2006 Apr; 7(2):E38. PubMed ID: 16796356
[TBL] [Abstract][Full Text] [Related]
8. Physicochemical characteristics and bioavailability of a novel intestinal metabolite of ginseng saponin (IH901) complexed with beta-cyclodextrin.
Lee PS; Han JY; Song TW; Sung JH; Kwon OS; Song S; Chung YB
Int J Pharm; 2006 Jun; 316(1-2):29-36. PubMed ID: 16574357
[TBL] [Abstract][Full Text] [Related]
9. Comparison of a revaprazan-loaded solid dispersion, solid SNEDDS and inclusion compound: Physicochemical characterisation and pharmacokinetics.
Park JH; Kim DS; Mustapha O; Yousaf AM; Kim JS; Kim DW; Yong CS; Youn YS; Oh KT; Lim SJ; Kim JO; Choi HG
Colloids Surf B Biointerfaces; 2018 Feb; 162():420-426. PubMed ID: 29248606
[TBL] [Abstract][Full Text] [Related]
10. Characterization and In Vitro Evaluation of the Complexes of Posaconazole with β- and 2,6-di-O-methyl-β-cyclodextrin.
Tang P; Wang L; Ma X; Xu K; Xiong X; Liao X; Li H
AAPS PharmSciTech; 2017 Jan; 18(1):104-114. PubMed ID: 26883260
[TBL] [Abstract][Full Text] [Related]
11. Development of a myricetin/hydroxypropyl-β-cyclodextrin inclusion complex: preparation, characterization, and evaluation.
Yao Y; Xie Y; Hong C; Li G; Shen H; Ji G
Carbohydr Polym; 2014 Sep; 110():329-37. PubMed ID: 24906763
[TBL] [Abstract][Full Text] [Related]
12. The unexpected increase of clotrimazole apparent solubility using randomly methylated β-cyclodextrin.
Pradines B; Gallard JF; Iorga BI; Gueutin C; Ponchel G; Loiseau PM; Bouchemal K
J Mol Recognit; 2015 Feb; 28(2):96-102. PubMed ID: 25604751
[TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo evaluation of a posaconazole-sulfobutyl ether-β-cyclodextrin inclusion complex.
Wang M; Jiang J; Cai Y; Zhao M; Wu Q; Cui Y; Zhao C
Biomed Chromatogr; 2018 Dec; 32(12):e4364. PubMed ID: 30119143
[TBL] [Abstract][Full Text] [Related]
15. Nanosuspensions Containing Oridonin/HP-β-Cyclodextrin Inclusion Complexes for Oral Bioavailability Enhancement via Improved Dissolution and Permeability.
Zhang X; Zhang T; Lan Y; Wu B; Shi Z
AAPS PharmSciTech; 2016 Apr; 17(2):400-8. PubMed ID: 26187778
[TBL] [Abstract][Full Text] [Related]
16. Enhanced oral bioavailability of flurbiprofen by combined use of micelle solution and inclusion compound.
Li DX; Han MJ; Balakrishnan P; Yan YD; Oh DH; Joe JH; Seo Y; Kim JO; Park SM; Yong CS; Choi HG
Arch Pharm Res; 2010 Jan; 33(1):95-101. PubMed ID: 20191350
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo evaluation of oral tablet formulations prepared with ketoconazole and hydroxypropyl-beta-cyclodextrin.
Taneri F; Ozcan I; Guneri T
Drug Deliv; 2010 Apr; 17(3):152-7. PubMed ID: 20148713
[TBL] [Abstract][Full Text] [Related]
18. Development and evaluation of orally disintegrating tablets of cilostazol-β-cyclodextrin inclusion complexes.
Desai C; Prabhakar B
Drug Dev Ind Pharm; 2015; 41(10):1589-607. PubMed ID: 25350555
[TBL] [Abstract][Full Text] [Related]
19. Physicochemical characteristics and oral bioavailability of andrographolide complexed with hydroxypropyl-beta-cyclodextrin.
Ren K; Zhang Z; Li Y; Liu J; Zhao D; Zhao Y; Gong T
Pharmazie; 2009 Aug; 64(8):515-20. PubMed ID: 19746840
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of itraconazole after intravenous and oral dosing of itraconazole-cyclodextrin formulations.
Buchanan CM; Buchanan NL; Edgar KJ; Klein S; Little JL; Ramsey MG; Ruble KM; Wacher VJ; Wempe MF
J Pharm Sci; 2007 Nov; 96(11):3100-16. PubMed ID: 17712849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
